ESC 365 - Hypertriglyceridaemia as a Causal Factor and Target for Therapy.

Open Access

Hypertriglyceridaemia as a Causal Factor and Target for Therapy.

Session: Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl

Topic: Cardiovascular Risk Assessment

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Sponsored by Amarin Pharma, Inc.

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Borge Nordestgaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

10 presentations

4 followers

4 more presentations in this session

Welcome and Introductions, Program Overview.

Speaker: Professor P. Steg (Paris, FR)

Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD.

Speaker: Professor P. Steg (Paris, FR)

Practical Considerations on Using Omega-3 Fatty Acids to Prevent ASCVD.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Live Q&A and Adjourn.

Speaker: Professor P. Steg (Paris, FR) Professor B. Nordestgaard (Copenhagen, DK)

Access the full session

Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl

Speakers: Professor B. Nordestgaard, Professor P. Steg, Professor P. Steg, Professor B. Nordestgaard, Professor P. Steg...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources